Spectral Medical Inc

Spectral Medical Inc

0.76
USD
+0.03
(+3.81%)
0.00EPS
238.48MMarket Cap
Mar 19Next Earn

Total Valuation

USD

As of September 30, 2026, Spectral Medical Inc. carries a market capitalization of 238.48M, placing it among publicly traded companies globally. Its enterprise value stands at 256.44M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap238.48M
Enterprise Value256.44M

Important Dates

Spectral Medical Inc.'s next confirmed earnings release is scheduled for March 19, 2027.

Earnings Date3/19/2027

Share Statistics

As of September 30, 2026, Spectral Medical Inc. has 293.55M shares outstanding.

Shares Outstanding293.55M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 156.27, and the price-to-book ratio stands at -5.33.

PS Ratio156.27
PB Ratio-5.33
P/TBV Ratio-5.30
P/FCF Ratio-37.54
P/OCF Ratio-35.74

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 168.22 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 256.44M versus a market cap of 238.48M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales168.22

Financial Position

As of September 30, 2026, Spectral Medical Inc. maintains a current ratio of 0.04, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -41.48, indicating conservative leverage, while an interest coverage ratio of -1.59 demonstrates limited ability to service its debt obligations.

Current Ratio0.04
Quick Ratio0.02
Debt / Equity-41.48
Debt / EBITDA-2.44
Interest Coverage-1.59

Financial Efficiency

USD

These figures cover the twelve months ended September 30, 2026. Return on assets (ROA) is negative at -6.22, reflecting losses generated across the asset base. The company generates approximately 52,566.07 in revenue per employee across its workforce of 29.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.87 indicates how many times Spectral Medical Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-6.22
Revenue Per Employee52,566.07
Employee Count29.00
Inventory Turnover3.87

Stock Price Statistics

USD

As of the close on November 16, 2026, Spectral Medical Inc.'s stock has declined approximately 25.71% over the past 52 weeks. The 50-day moving average sits at 0.81, while the 200-day moving average is 0.94.

52-Week Price Change-25.71%
50-Day Moving Average0.81
200-Day Moving Average0.94

Income Statement

USD

Over the twelve months ended September 30, 2026, Spectral Medical Inc. generated 1.52M in revenue and converted that into -242,472.80 in net income, yielding earnings per share of 0.00. EBITDA reached -7.60M, while operating income came in at -7.78M.

Revenue1.52M
Gross Profit461,752.55
Operating Income-7.78M
Pretax Income-238,958.70
Net Income-242,472.80
EBITDA-7.60M
EBIT-7.78M

Balance Sheet

USD

As of September 30, 2026, Spectral Medical Inc. holds 610,750.33 in cash and equivalents against 18.56M in total debt, resulting in a net debt position of 17.76M. Total book value stands at -44.76M, with working capital of -36.61M providing operational flexibility.

Cash & Cash Equivalents610,750.33
Total Debt18.56M
Net Debt17.76M
Equity (Book Value)-44.76M
Book Value Per Share-0.15
Working Capital-36.61M

Cash Flow

USD

Spectral Medical Inc. produced -6.66M in operating cash flow over the twelve months ended September 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -6.66M - equivalent to -0.02 per share.

Operating Cash Flow-6.66M
Free Cash Flow-6.66M
FCF Per Share-0.02

Margins

Over the twelve months ended September 30, 2026, Spectral Medical Inc. posted a gross margin of 30.29, reflecting its pricing power and cost economics. The operating margin of -510.05 and net profit margin of -15.91 provide insight into operational efficiency.

Gross Margin30.29
Operating Margin-510.05
Pretax Margin-15.68
Profit Margin-15.91
EBITDA Margin-498.57

Dividends & Yields

Over the twelve months ended September 30, 2026, Spectral Medical Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -2.66: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.31, meaning Spectral Medical Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-1.31
FCF Yield-2.66

Scores

As of September 30, 2026, Spectral Medical Inc. has an Altman Z-Score of -130.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-130.36